Loading publications…
The last 5 uploaded publications
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels
Shirley Uitte de Willige, Marieke C. Visser, Jeanine J. Houwing‐Duistermaat, Frits R. Rosendaal, Hans L. Vos, Rogier M. Bertina (2005). Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels. Blood, 106(13), pp. 4176-4183, DOI: 10.1182/blood-2005-05-2180.
Article126 days agoHaplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis
Shirley Uitte de Willige, Vincent Marion, Frits R. Rosendaal, Hans L. Vos, Marieke C. Visser, Rogier M. Bertina (2004). Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. Journal of Thrombosis and Haemostasis, 2(8), pp. 1305-1310, DOI: 10.1046/j.1538-7836.2004.00855.x.
Article126 days agoProteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction
Shirley Uitte de Willige, Megan Miedzak, Angela M. Carter, Ton Lisman, Frits R. Rosendaal, Peter J. Grant, Helen Philippou, Robert A. S. Ariëns (2011). Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction. Blood, 117(24), pp. 6694-6701, DOI: 10.1182/blood-2010-11-320325.
Article126 days agoHaplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction
Shirley Uitte de Willige, Carine J.M. Doggen, Marieke C. Visser, Rogier M. Bertina, Frits R. Rosendaal (2006). Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction. Journal of Thrombosis and Haemostasis, 4(2), pp. 474-476, DOI: 10.1111/j.1538-7836.2006.01716.x.
Letter126 days ago